SC
VERA icon

Steven Cohen’s Vera Therapeutics VERA Stock Holding History

Steven Cohen’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.74M Sell
40,563
-1,170,162
-97% -$43.6M ﹤0.01% 2478
2026
Q1 		$48.7M Sell
1,210,725
-527,660
-30% -$22.7M 0.06% 381
2025
Q4 		$88M Buy
1,738,385
+466,358
+37% +$16.6M 0.1% 214
2025
Q3 		$37M Buy
+1,272,027
New +$29.4M 0.06% 336
2025
Q1 		– Sell
-194,027
Closed -$8.21M – 2568
2024
Q4 		$8.21M Buy
194,027
+22,454
+13% +$994K 0.02% 754
2024
Q3 		$7.58M Buy
171,573
+52,573
+44% +$2M 0.02% 751
2024
Q2 		$4.31M Sell
119,000
-1,056,148
-90% -$41.9M 0.01% 881
2024
Q1 		$50.7M Buy
1,175,148
+190,824
+19% +$6.8M 0.12% 197
2023
Q4 		$15.1M Buy
+984,324
New +$12.5M 0.04% 542
2023
Q2 		– Sell
-1,037,128
Closed -$8.05M – 2815
2023
Q1 		$8.05M Buy
+1,037,128
New +$8.01M 0.02% 622
2022
Q4 		– Sell
-121,000
Closed -$2.58M – 1807
2022
Q3 		$2.58M Buy
+121,000
New +$2.27M 0.01% 875

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Steven Cohen's VERA Position: Q2 2026 in Review

Steven Cohen reduced its Vera Therapeutics (VERA) stake by 97% in Q2 2026, selling an estimated $43.6M and leaving 40,563 shares worth $1.74M. The position accounts for ﹤0.01% of the portfolio, ranked #2478.

Steven Cohen first reported a position in VERA in Q3 2022 and has held it in 11 quarters since. The position peaked at $88M in Q4 2025. 218 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Steven Cohen held 40,563 shares of Vera Therapeutics worth $1.74M as of Q2 2026.
  • Steven Cohen sold 1,170,162 Vera Therapeutics shares in Q2 2026, an estimated $43.6M.
  • Vera Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #2478 holding.
  • Steven Cohen first reported a position in Vera Therapeutics in Q3 2022 and has held it in 11 quarters since.
  • Steven Cohen's Vera Therapeutics position peaked at $88M in Q4 2025.
  • 218 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.